As I feared, the stock market almost yawned, despite today's huge news of an unexpectedly quick BT designation.  There are enough sellers at a  higher price to keep a lid on this share price.

I know...this is a tightly held stock etc. etc...but the price is the price. The price is the wisdom of the crowds, whether you like it or not.  In RVX's case, it also captures the near absence of institutional investors, so it realistically captures all the information, whether you like it or not.

The close at $1.33 is eerie...this is the price at which RVX was going to hand out shares to the warrant holders. So I guess the market is unwilling to take RVX any higher until the cash on hand issue has been at least addressed.  Does RVX now go back to those warrant holders and beg them once again to cough up the cash?  

Now that the BT designation is behind us, the question is...what next? It can't be the eGFR data...all the possible buyers must already know it, based on confidentiality agreements.  The BT designation absolutely helps...but is it enough to get a buyer to pony up, say even a bare bones $2 billion?  I am not going to believe it, until I see some credible smoke signals.

One thing I am clear: I don't want to see a partnership.  That would mean years of waiting for some trials to finish...and then feel ultimately cheated by being bought out on the cheap by whoever partners up with RVX.

It is best that the company be sold to the highest bidder.  RVX now belongs inside another company where capital is not an issue, and all manner of huge and varied trials can be conducted.  

Icon